Shanghai Obio Technology (Group) Corp., Ltd. (SHA:688238)

China · Delayed Price · Currency is CNY

7.71

+0.38 (5.18%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Gene Therapy CRO Service	85.82M				36.69M	36.09M	29.35M	-
Gene Therapy CRO Service Growth	-				1.67%	22.95%	-	-
Gene Therapy CDMO Service	134.94M				101.71M	24.83M	12.91M	-
Gene Therapy CDMO Service Growth	-				309.64%	92.31%	-	-
Regenerative Medicine Services	316.96K				-	-	-	-
Biological Agents, Reagents and Others	27.07M				3.91M	1.93M	1.09M	-
Biological Agents, Reagents and Others Growth	-				102.97%	77.34%	-	-
Mechanism and Function Service	-				-	-	-	6.60M
CRO/CDMO/CMO Business	-				-	-	-	443.32K
Merchandise Sales and Others	-				-	-	-	2.56M
Pre-Made Virus Service	-				-	-	-	5.08M
Custom Virus Service	-				-	-	-	13.14M
Total	248.15M				142.31M	62.84M	43.35M	27.83M
Total Growth	-				126.46%	44.98%	55.78%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Eastern Region	147.55M				72.37M	-	-	-
South China	26.06M				35.75M	-	-	-
Northern Region	39.26M				10.46M	-	-	-
Southwest	8.84M				18.48M	-	-	-
Others	21.70M				4.89M	-	-	-
Overseas	1.62M				360.74K	-	-	-
Total	245.02M				142.31M	-	-	-

Source: S&P Global Market Intelligence.